Profil
David Feltquate currently works at iTeos Therapeutics, Inc., as Chief Medical Officer from 2024.
Dr. Feltquate also formerly worked at Novartis, Inc., as Chairman-Precision Medicine Leadership Team from 2020 to 2021, Bristol Myers Squibb Co., as Head-Early Clinical Development from 2016 to 2019, and Palleon Pharmaceuticals, Inc., as Chief Medical Officer from 2021 to 2024.
Dr. Feltquate received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from UMass Chan Medical School.
Postes actifs de David Feltquate
| Sociétés | Poste | Début |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 05/08/2024 |
Anciens postes connus de David Feltquate
| Sociétés | Poste | Fin |
|---|---|---|
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Directeur Technique/Scientifique/R&D | 01/07/2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01/06/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2019 |
Formation de David Feltquate
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
















